HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wei Wei Selected Research

paeonol

9/2013Inhibitory effects of salidroside and paeonol on tyrosinase activity and melanin synthesis in mouse B16F10 melanoma cells and ultraviolet B-induced pigmentation in guinea pig skin.
1/2013Endoplasmic reticulum stress-induced resistance to doxorubicin is reversed by paeonol treatment in human hepatocellular carcinoma cells.
4/2008Anti-tumor effects of paeonol in a HepA-hepatoma bearing mouse model via induction of tumor cell apoptosis and stimulation of IL-2 and TNF-alpha production.
6/2007Synergistic effect of combining paeonol and cisplatin on apoptotic induction of human hepatoma cell lines.
1/2007Antiproliferation and apoptosis induction of paeonol in HepG2 cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wei Wei Research Topics

Disease

592Neoplasms (Cancer)
12/2022 - 08/2003
119Hepatocellular Carcinoma (Hepatoma)
10/2022 - 05/2003
104Inflammation (Inflammations)
07/2022 - 07/2005
102Breast Neoplasms (Breast Cancer)
04/2022 - 05/2008
90Neoplasm Metastasis (Metastasis)
05/2022 - 07/2004
82Infections
12/2022 - 12/2006
60Experimental Arthritis
08/2022 - 09/2002
60Rheumatoid Arthritis
07/2022 - 07/2008
49Arthritis (Polyarthritis)
07/2022 - 09/2002
43Carcinogenesis
12/2022 - 11/2006
42Fibrosis (Cirrhosis)
03/2022 - 04/2005
36Pain (Aches)
09/2022 - 03/2006
34COVID-19
08/2022 - 01/2020
33Prostatic Neoplasms (Prostate Cancer)
08/2022 - 01/2015
32Stomach Neoplasms (Stomach Cancer)
10/2022 - 05/2010
32Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 02/2009
29Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2022 - 01/2007
29Necrosis
01/2021 - 10/2002
28Lung Neoplasms (Lung Cancer)
10/2022 - 01/2009
28Carcinoma (Carcinomatosis)
04/2022 - 08/2003
28Alzheimer Disease (Alzheimer's Disease)
12/2021 - 01/2005
27Colorectal Neoplasms (Colorectal Cancer)
06/2022 - 05/2007
27Wounds and Injuries (Trauma)
01/2022 - 03/2007
26Hypoxia (Hypoxemia)
03/2022 - 01/2005
26Body Weight (Weight, Body)
01/2022 - 05/2006
25Type 2 Diabetes Mellitus (MODY)
08/2022 - 01/2011
24Autoimmune Diseases (Autoimmune Disease)
08/2022 - 01/2009
22Melanoma (Melanoma, Malignant)
02/2021 - 08/2012
20Pancreatic Neoplasms (Pancreatic Cancer)
01/2021 - 05/2013
19Insulin Resistance
06/2022 - 12/2009
18Glioma (Gliomas)
02/2022 - 02/2008
18Obesity
01/2022 - 03/2011
18Multiple Myeloma
01/2021 - 06/2010
17Leukemia
12/2022 - 08/2008
17Hypothyroidism
12/2021 - 03/2010
16Cardiovascular Diseases (Cardiovascular Disease)
08/2022 - 12/2009
16Liver Cirrhosis (Hepatic Cirrhosis)
07/2021 - 07/2004
16Lymphatic Metastasis
06/2021 - 01/2007
15Atherosclerosis
05/2022 - 06/2003
14Hemorrhage
01/2022 - 07/2007
14Stroke (Strokes)
11/2021 - 07/2003
14Triple Negative Breast Neoplasms
06/2021 - 11/2013
13Dyspepsia (Indigestion)
06/2022 - 06/2007
13Mitochondrial Diseases (Mitochondrial Disease)
05/2022 - 02/2009
13Sepsis (Septicemia)
05/2022 - 03/2005
13Glioblastoma (Glioblastoma Multiforme)
01/2022 - 01/2012
13Atrial Fibrillation
01/2021 - 01/2009

Drug/Important Bio-Agent (IBA)

199Proteins (Proteins, Gene)FDA Link
12/2022 - 01/2005
106Biomarkers (Surrogate Marker)IBA
12/2022 - 01/2007
98Pharmaceutical PreparationsIBA
08/2022 - 10/2007
70MicroRNAs (MicroRNA)IBA
05/2022 - 08/2008
60Biological ProductsIBA
12/2022 - 08/2003
53CytokinesIBA
01/2022 - 07/2005
47Therapeutic UsesIBA
05/2022 - 11/2004
45Messenger RNA (mRNA)IBA
05/2022 - 07/2004
31Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2022 - 10/2002
30Glucose (Dextrose)FDA LinkGeneric
06/2022 - 05/2007
30Long Noncoding RNAIBA
05/2022 - 01/2016
30Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2022 - 06/2002
27Peptides (Polypeptides)IBA
05/2022 - 01/2005
27AntigensIBA
05/2022 - 03/2006
26DNA (Deoxyribonucleic Acid)IBA
12/2022 - 07/2009
26EnzymesIBA
06/2022 - 11/2008
25RNA (Ribonucleic Acid)IBA
01/2022 - 07/2005
24Indicators and Reagents (Reagents)IBA
05/2022 - 07/2010
24CollagenIBA
03/2022 - 04/2005
24Small Interfering RNA (siRNA)IBA
11/2021 - 09/2010
23Reactive Oxygen Species (Oxygen Radicals)IBA
05/2022 - 12/2006
23MelatoninIBA
12/2021 - 09/2002
22CateninsIBA
03/2022 - 12/2011
22IodineIBA
01/2022 - 03/2010
21Interleukin-6 (Interleukin 6)IBA
05/2022 - 04/2006
21AntibodiesIBA
01/2022 - 11/2007
21peoniflorinIBA
12/2021 - 04/2006
20Phosphotransferases (Kinase)IBA
10/2022 - 04/2013
20LigandsIBA
04/2022 - 08/2008
20LipopolysaccharidesIBA
01/2022 - 12/2005
19Cisplatin (Platino)FDA LinkGeneric
02/2021 - 02/2005
18LipidsIBA
01/2022 - 06/2003
17Methotrexate (Mexate)FDA LinkGeneric
06/2022 - 07/2008
17Oxygen (Dioxygen)IBA
06/2022 - 01/2005
16Paclitaxel (Taxol)FDA LinkGeneric
05/2022 - 03/2011
16GlucosidesIBA
01/2019 - 04/2003
15Transcription Factors (Transcription Factor)IBA
12/2022 - 10/2005
15Estrogen ReceptorsIBA
10/2021 - 06/2014
14ErbB Receptors (EGF Receptor)IBA
10/2022 - 07/2004
14Immune Checkpoint InhibitorsIBA
05/2022 - 12/2017
14VaccinesIBA
01/2022 - 04/2009
14AlbuminsIBA
09/2021 - 11/2008
14Doxorubicin (Adriamycin)FDA LinkGeneric
01/2020 - 01/2007
13Caspase 3 (Caspase-3)IBA
01/2022 - 03/2005
13Hormones (Hormone)IBA
01/2021 - 05/2008
12Fluorouracil (Carac)FDA LinkGeneric
10/2022 - 01/2007
12Oxaliplatin (Eloxatin)FDA LinkGeneric
10/2022 - 06/2010

Therapy/Procedure

226Therapeutics
12/2022 - 08/2003
85Drug Therapy (Chemotherapy)
12/2022 - 02/2007
41Radiotherapy
07/2022 - 04/2008
38Immunotherapy
12/2022 - 03/2009
17Neoadjuvant Therapy
01/2022 - 01/2013
16Aftercare (After-Treatment)
04/2022 - 11/2013